Central Pharmaceutical Joint Stock Company N.3 owns a manufacturing factory that complies with WHO-GMP standards. This modern facility has been invested in and constructed on a land area of 3,200 m². The facility includes specifically allocated areas, clearly defined based on their purposes, such as:

• Production area
• Departments (Quality assurance, R&D, quality control, electro-mechanic department)
• Technical area (Non-betaclactam production line for tablets and powder, production line for ointments and liquid medicine for external use, HVAC system)

The company's GMP factory is equipped with modern systems and advanced equipment, including:

• Non-betaclactam production line for tablets and powder has an area of about 486 m²:

Raw material receiving room, raw material storage room, primary packaging material storage room, material processing room, high-speed mixing room, fluid bed drying room, cubic blending room, compressed tablet storage and powder storage room, tablet compression rooms 1, 2, and 3, film-coating room, capsule filling room, semi-finished tablet packaging room, blister packaging room, foil pouch packaging rooms 1 and 2, bottle filling room, and semi-finished blister product storage room. Secondary packaging room has an area of 100 m². Once in full operation, the facility will supply 100 million tablets per year and 10 million powders per year.

• Production line for ointments and liquid medicine for external use has an area of 260 m², including:

Primary packaging material storage room, buffer room, material storage room, compounding room, filling and capping room, semi-finished product storage room, and secondary packaging room.

Primary packaging material storage room, buffer room, material storage room, compounding and dosing room, semi-finished product storage room, and secondary packaging room.

Once in full operation, the facility will supply: 3 million aromatic balm per year, and 30 million liquid bottles per year.

Additionally, the company also places significant emphasis on investing in advanced infrastructure systems, ensuring compliance with the set standards.

• HVAC system
• RO system
• Compressed air systems
• Wastewater treatment system

​

Based on the experience and standards established in the manufacturing plant, the company has also constructed a production line for health supplements that meets GMP standards. With numerous trusted products, it has generated high annual profits